Replies to post #1138 on BioCardia Inc (BCDA)

[realfast95]

Trial due dates from 4/2019 10k

We have enrolled 32 patients in the trial to date and enrollment is anticipated to begin accelerating due to additional compelling data presented from the
roll in cohort, the addition of world class centers to the trial, and the completion of competitive clinical programs. We anticipate a first interim readout
from the trial in Q3 2019, a second interim readout in Q3 2020, that trial enrollment will be completed in Q3 2020 and that top line data will be available
in Q3 2021.

======================
This is a big trial delay compared what they wrote in the 2018 10K (1.5 years later)

DEAD MONEY